UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies

Clinical cancer research, 2016-10, Vol.22 (20), p.5049-5057

2016

Link zum Volltext

Verfügbarkeit prüfen

Brentuximab vedotin, an antibody–drug conjugate, in patients with CD30‐positive haematologic malignancies and hepatic or renal impairment

British journal of clinical pharmacology, 2016-09, Vol.82 (3), p.696-705

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C

Investigational new drugs, 2017-04, Vol.35 (2), p.235-241

2017

Link zum Volltext

Verfügbarkeit prüfen

TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study

Cancer Research and Treatment, 2018, 50(2), , pp.398-404

2018

Link zum Volltext

Verfügbarkeit prüfen

Absence of Adverse Effects in Cynomolgus Macaques Treated with CNTO 95, a Fully Human Anti-αv Integrin Monoclonal Antibody, Despite Widespread Tissue Binding

Clinical cancer research, 2005-10, Vol.11 (19), p.6959-6965

2005

Link zum Volltext

Verfügbarkeit prüfen

T1132 Pharmacokinetics and Exposure-Response Relationship of Ustekinumab, a Human Monoclonal Antibody to Interleukin 12/23, in Patients with Moderate-to-Severe Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-490-A-490

2008

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of thermal decomposition of 4-carboxyl-2,6-dinitrobenzenediazonium ion (CDNBD)

Journal of AOAC International, 2005-07, Vol.88 (4), p.1108

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of the Investigational Anti-Guanylyl Cyclase AntibodyDrug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies

Clinical cancer research, 2016-10, Vol.22 (20), p.5049-5057

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT107: Phase II trial of TAK-264 in previously treated patients (pts) with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expression guanylyl cyclase C (GCC)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT107-CT107

2016

Link zum Volltext

Verfügbarkeit prüfen

MLN0264, an investigational antiguanylyl cyclase C (GCC) antibody-drug conjugate (ADC), in patients (pts) with advanced gastrointestinal (GI) malignancies: Phase I study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.3546-3546

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT117: A phase II trial of TAK-264, a novel antibody-drug conjugate (ADC), in patients with pancreatic adenocarcinoma expressing guanylyl cyclase C (GCC)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT117-CT117

2016

Link zum Volltext

Verfügbarkeit prüfen

Mln0264, an Investigational, First-In-Class Antibody-Drug Conjugate Targeting Guanylyl Cyclase C (Gcc): First-In-Human Study in Patients with Advanced Gastrointestinal Malignancies

Annals of oncology, 2013-06, Vol.24, p.iv36-iv36

2013

Link zum Volltext

Verfügbarkeit prüfen

TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study

Cancer research and treatment, 2018-04, p.398-404

2018

Link zum Volltext

Verfügbarkeit prüfen

MLN0264, an investigational, first-in-class antibody-drug conjugate (ADC) targeting guanylyl cyclase C (GCC): Phase I, first-in-human study in patients (pts) with advanced gastrointestinal (GI) malignancies expressing GCC

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS3646-TPS3646

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase 1/2 Study Of Brentuximab Vedotin In Pediatric Patients With Relapsed Or Refractory (R/R) Hodgkin Lymphoma (HL) Or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 Data For Brentuximab Vedotin 1.8 Mg/Kg In The HL Study Arm

Blood, 2013-11, Vol.122 (21), p.4378-4378

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study of brentuximab vedotin in pediatric patients (pts) with relapsed or refractory (RR) Hodgkin lymphoma (HL) or systemic anaplastic large-cell lymphoma (sALCL): Interim phase (ph) I safety data

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.10028-10028

2013

Link zum Volltext

Verfügbarkeit prüfen

Determination of chlorpromazine and its sulphoxide in pharmaceutical dosage forms by third-order derivative ultraviolet spectroscopy

Analyst (London), 1985, Vol.110 (9), p.1117-1124

1985

Link zum Volltext

Verfügbarkeit prüfen

Computer-aided time domain differentiation in high-performance liquid chromatography

Analytical chemistry (Washington), 1989-04, Vol.61 (7), p.720-728

1989

Link zum Volltext

Verfügbarkeit prüfen

Flavonoids from Vernonia amygdalina and their antioxidant activities. [Erratum to document cited in CA121:251243]

Journal of agricultural and food chemistry, 1995-05, Vol.43 (5), p.1420-1420

1995

Link zum Volltext

Verfügbarkeit prüfen

Ultraviolet Spectral Features Affecting Computer-Aided Multiwavelength Quantitation of Multicomponent Mixtures Using Phenothiazines as Model

Analytical letters, 1994-07, Vol.27 (10), p.1955-1977

Fasanmade, Adedigbo A.

1994

Link zum Volltext

Verfügbarkeit prüfen

Infliximab pharmacokinetics and improvement in fistulizing Crohn's disease

Gastroenterology (New York, N.Y. 1943), 2003-04, Vol.124 (4), p.A61-A61

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck

Journal of clinical oncology, 1998-02, Vol.16 (2), p.735-744

1998

Link zum Volltext

Verfügbarkeit prüfen

THE ANALYSIS OF TRACE ALKALOIDS IN HEROIN BY SECOND-ORDER DERIVATIVE HIGH PRESSURE LIQUID CHROMATOGRAPHY WITH RAPID SCANNING DETECTION

Journal of pharmacy and pharmacology, 1985-12, Vol.37 (S12), p.128P-128P

1985

Link zum Volltext

Verfügbarkeit prüfen

Gelation Kinetics of Dilute Hemogln from Sickle Cell Anemia Patients

Hemoglobin, 1996, Vol.20 (4), p.415-428

Fasanmade, Adedigbo A.

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaInfliximab

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies

Brentuximab vedotin, an antibody–drug conjugate, in patients with CD30‐positive haematologic malignancies and hepatic or renal impairment

Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C

TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study

Absence of Adverse Effects in Cynomolgus Macaques Treated with CNTO 95, a Fully Human Anti-αv Integrin Monoclonal Antibody, Despite Widespread Tissue Binding

T1132 Pharmacokinetics and Exposure-Response Relationship of Ustekinumab, a Human Monoclonal Antibody to Interleukin 12/23, in Patients with Moderate-to-Severe Crohn's Disease

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C

Kinetics of thermal decomposition of 4-carboxyl-2,6-dinitrobenzenediazonium ion (CDNBD)

Phase I Study of the Investigational Anti-Guanylyl Cyclase AntibodyDrug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies

Abstract CT107: Phase II trial of TAK-264 in previously treated patients (pts) with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expression guanylyl cyclase C (GCC)

MLN0264, an investigational antiguanylyl cyclase C (GCC) antibody-drug conjugate (ADC), in patients (pts) with advanced gastrointestinal (GI) malignancies: Phase I study

Abstract CT117: A phase II trial of TAK-264, a novel antibody-drug conjugate (ADC), in patients with pancreatic adenocarcinoma expressing guanylyl cyclase C (GCC)

Mln0264, an Investigational, First-In-Class Antibody-Drug Conjugate Targeting Guanylyl Cyclase C (Gcc): First-In-Human Study in Patients with Advanced Gastrointestinal Malignancies

TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study

MLN0264, an investigational, first-in-class antibody-drug conjugate (ADC) targeting guanylyl cyclase C (GCC): Phase I, first-in-human study in patients (pts) with advanced gastrointestinal (GI) malignancies expressing GCC

Phase 1/2 Study Of Brentuximab Vedotin In Pediatric Patients With Relapsed Or Refractory (R/R) Hodgkin Lymphoma (HL) Or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 Data For Brentuximab Vedotin 1.8 Mg/Kg In The HL Study Arm

Phase I/II study of brentuximab vedotin in pediatric patients (pts) with relapsed or refractory (RR) Hodgkin lymphoma (HL) or systemic anaplastic large-cell lymphoma (sALCL): Interim phase (ph) I safety data

Determination of chlorpromazine and its sulphoxide in pharmaceutical dosage forms by third-order derivative ultraviolet spectroscopy

Computer-aided time domain differentiation in high-performance liquid chromatography

Flavonoids from Vernonia amygdalina and their antioxidant activities. [Erratum to document cited in CA121:251243]

Ultraviolet Spectral Features Affecting Computer-Aided Multiwavelength Quantitation of Multicomponent Mixtures Using Phenothiazines as Model

Infliximab pharmacokinetics and improvement in fistulizing Crohn's disease

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck

THE ANALYSIS OF TRACE ALKALOIDS IN HEROIN BY SECOND-ORDER DERIVATIVE HIGH PRESSURE LIQUID CHROMATOGRAPHY WITH RAPID SCANNING DETECTION

Gelation Kinetics of Dilute Hemogln from Sickle Cell Anemia Patients

Aktive Filter

Suchergebnisse filtern